A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A study among adults, children and infants in Kenya to determine if a new type of glycoconjugate vaccine incorporating a synthetic carbohydrate component is safe and induces immunity against Shigella.
Epistemonikos ID: ba2ee23a436e1e33f01087036ae60c860828a0dc
First added on: May 07, 2024